BioPharma Credit PLC Notice of AGM (4806L)
May 13 2022 - 7:35AM
UK Regulatory
TIDMBPCR
RNS Number : 4806L
BioPharma Credit PLC
13 May 2022
13 May 2022
BioPharma Credit plc
(the "Company")
NOTICE OF ANNUAL GENERAL MEETING
Following the publication on 22 March 2022 of its Annual
Financial Report for the year ended 31 December 2021, the Company
announces that it will hold its Annual General Meeting ("AGM") at
1.00 p.m. on 9 June 2022 at the offices of Herbert Smith Freehills
LLP, Exchange House, Primrose Street, London EC2A 2EG.
A copy of the Notice of the AGM is available to view on the
Company's website at http://www.bpcruk.com. It has also been
submitted to the National Storage Mechanism and is available for
inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism . Copies of
the Notice of the AGM have been posted or made available to the
Company's Shareholders.
Enquiries:
BioPharma Credit plc
via Link Company Matters Limited
Company Secretary
+44 (0)1392 477 500
Buchanan
David Rydell / Mark Court / Jamie Hooper / Henry Wilson
+44 (0)20 7466 5000
biopharmacredit@buchanan.uk.com
Notes to Editors:
BioPharma Credit PLC is London's only listed specialist investor
in debt from the life sciences industry and joined the LSE on 27
March 2017. The Company seeks to provide long-term shareholder
returns, principally in the form of sustainable income
distributions from exposure to the life sciences industry. The
Company seeks to achieve this objective primarily through
investments in debt assets secured by royalties or other cash flows
derived from the sales of approved life sciences products.
LEI: 213800AV55PYXAS7SY24
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOASFLFFDEESEDI
(END) Dow Jones Newswires
May 13, 2022 07:35 ET (11:35 GMT)
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From Apr 2024 to May 2024
Biopharma Credit (LSE:BPCR)
Historical Stock Chart
From May 2023 to May 2024